General Atlantic (SP), L.P.
CIK: 0002133363
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPTX
Seaport Therapeutics, Inc.
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About General Atlantic (SP), L.P.
General Atlantic (SP), L.P. (SEC CIK 0002133363) files insider reports with the SEC as Director of Seaport Therapeutics, Inc. (SPTX).
Signal8 holds 1 ownership filing by General Atlantic (SP), L.P., a Form 3, filed on May 6, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on General Atlantic (SP), L.P.'s filings is in NEW YORK, NY.
Other insiders filing for Seaport Therapeutics, Inc. (SPTX)
- HOMBACH ROBERT J., Director
- GAP Coinvestments CDA, L.P., Director
- PureTech Health plc, 10% Owner
- Zohar Daphne, Chief Executive Officer
- HEALY JAMES, Director
- White Lauren, Chief Financial Officer